A MULTICENTER, RANDOMIZED, SINGLE-BLIND EVALUATION OF CEFUROXIME AXETIL AND PHENOXYMETHYL PENICILLIN IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS

被引：28

作者：

PICHICHERO, ME

DISNEY, FA

ARONOVITZ, GH

GINSBURG, C

STILLERMAN, M

机构：

[1] UNIV ROCHESTER, SCH MED & DENT, DEPT PEDIAT, ROCHESTER, NY 14642 USA

[2] EMORY UNIV, DEPT PEDIAT, ATLANTA, GA 30322 USA

[3] UNIV TEXAS, HLTH SCI CTR, DEPT PEDIAT, DALLAS, TX 75235 USA

[4] SUNY STONY BROOK, DEPT PEDIAT, STONY BROOK, NY 11794 USA

来源：

CLINICAL PEDIATRICS | 1987年 / 26卷 / 09期

关键词：

D O I：

10.1177/000992288702600904

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：453 / 458

页数：6

共 24 条

[1] THE PREVENTION OF TYPE SPECIFIC IMMUNITY TO STREPTOCOCCAL INFECTIONS DUE TO THE THERAPEUTIC USE OF PENICILLIN - OCCURRENCE OF 2ND ATTACKS DUE TO THE SAME TYPE OF GROUP-A HEMOLYTIC STREPTOCOCCI [J].

BREESE, BB ;

DISNEY, FA ;

TALPEY, WB .

AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1960, 100 (03) :353-359

[2] INVIVO PROTECTION OF GROUP-A BETA-HEMOLYTIC STREPTOCOCCI FROM PENICILLIN BY BETA-LACTAMASE-PRODUCING BACTEROIDES SPECIES [J].

BROOK, I ;

PAZZAGLIA, G ;

COOLBAUGH, JC ;

WALKER, RI .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 (06) :599-606

[3]

DERRICK CW, 1974, CIRCULATION, V50, P38

[4]

DISNEY FA, 1979, POSTGRAD MED J, V55, P50

[5]

DISNEY FA, 1971, POSTGRAD MED J, V47, P47

[6]

GASTANADUY AS, 1980, LANCET, V2, P498

[7]

GAU DW, 1972, PRACTITIONER, V208, P276

[8]

GINSBURG CM, 1980, J INT MED RES, V8, P82

[9]

GINSBURGH CM, TREATMENT GROUP A ST

[10] CEFUROXIME - MECHANISMS OF ACTION, ANTI-MICROBIAL ACTIVITY, PHARMACOKINETICS, CLINICAL-APPLICATIONS, ADVERSE REACTIONS AND THERAPEUTIC INDICATIONS [J].

GOLD, B ;

RODRIGUEZ, WJ ;

PAPALEXIOU, P ;

BROEKHUYSEN, J ;

BOIKE, SC .

PHARMACOTHERAPY, 1983, 3 (02) :82-100

← 1 2 3 →